Remnant nephron physiology and the progression of chronic kidney disease

Pediatric Nephrology

Volumn 29, Issue 2, 2014, Pages 193-202

  Schnaper, H William ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; Fibrosis; Hypertrophy; Nephron; Reactive oxygen species

Indexed keywords

REACTIVE OXYGEN METABOLITE;

AEROBIC METABOLISM; CELL DEDIFFERENTIATION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HUMAN; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY ISCHEMIA; KIDNEY METABOLISM; KIDNEY TUBULE; KIDNEY TUBULE ACIDOSIS; NEPHRITIS; NEPHRON; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; UREMIA;

DISEASE PROGRESSION; HUMANS; NEPHRONS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84892792648     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2494-8     Document Type: Review

References (67)

1. Schnaper HW, Hubchak SC, Runyan CE, Browne JA, Finer G, Liu X, Hayashida T (2010) A conceptual framework for the molecular pathogenesis of progressive kidney disease. Pediatr Nephrol 25:2223-2230
2. Lewis J, Greene T, Appel L, Contreras G, Douglas J, Lash J, Toto R, Van Lente F, Wang X, Wright JT Jr (2004) A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 15:3175-3183 (Pubitemid 39578850)
3. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, Toto RD, Wang X, Wright JT Jr, Greene TH (2012) Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 59:504-512
4. Schaefer B, Wuhl E (2012) Educational paper: progression in chronic kidney disease and prevention strategies. Eur J Pediatr 171:1579-1588
5. Bricker NS (1972) On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis". N Engl J Med 286:1093-1099
6. Bricker NS, Fine LG, Kaplan M, Epstein M, Bourgoignie JJ, Light A (1978) "Magnification phenomenon" in chronic renal disease. N Engl J Med 299:1287-1293 (Pubitemid 9115798)
7. Eddy AA, Schnaper HW (1998) Nephrotic syndrome: from the simple to the complex. Semin Nephrol 18:295-316
8. Kriz W, LeHir M (2005) Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67:404-419 (Pubitemid 40139832)
9. Forbes MS, Thornhill BA, Chevalier RL (2011) Proximal tubular injury and rapid formation of atubular glomeruli in mice with unilateral ureteral obstruction: a new look at an old model. Am J Physiol Renal Physiol 301:F110-F117
10. Marcussen N (1992) Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 66:265-284
11. Komers R, Meyer TW, Anderson S (2013) Pathophysiology and nephron adaptation in chronic kidney disease. In: Coffman TM, Falk RJ, Molitoris BM, Neilson EG et al (eds) Schrier's diseases of the kidney and urinary tract, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2214-2237
12. Komers R, Oyama TT, Beard DR, Tikellis C, Xu B, Lotspeich DF, Anderson S (2011) Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Kidney Int 79:432-442
13. Taal MW, Brenner BM (2000) Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int 57:1803-1817 (Pubitemid 30252273)
14. Eddy AA (2005) Progression in chronic kidney disease. Adv Chronic Kidney Dis 12:353-365 (Pubitemid 41376493)
15. Robson AM, Mor J, Root ER, Jager BV, Shankel SW, Ingelfinger JR, Kienstra RA, Bricker NS (1979) Mechanism of proteinuria in nonglomerular renal disease. Kidney Int 16:416-429 (Pubitemid 10208504)
16. Quaggin SE, Kapus A (2011) Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int 80:41-50
17. Grgic I, Duffield JS, Humphreys BD (2012) The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 27:183-193
18. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19:2282-2287
19. Striker LM-M, Killen PD, Chi E, Striker GE (1984) The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 51:181-192 (Pubitemid 14064238)
20. Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ, Tsai MY, Cruickshanks KJ, Schubert CR, Brazy PC, Coresh J, Klein R (2011) Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 80:1231-1238
21. Li L, Huang L, Sung SS, Vergis AL, Rosin DL, Rose CE Jr, Lobo PI, Okusa MD (2008) The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 74:1526-1537
22. Brahler S, Ising C, Hagmann H, Rasmus M, Hoehne M, Kurschat C, Kisner T, Goebel H, Shankland SJ, Addicks K, Thaiss F, Schermer B, Pasparakis M, Benzing T, Brinkkoetter PT (2012) Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria. Am J Physiol Renal Physiol 303:F1473-F1485
23. Wada J, Makino H (2013) Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond) 124:139-152
24. Abbate M, Zoja C, Corna D, Rottoli D, Zanchi C, Azzollini N, Tomasoni S, Berlingeri S, Noris M, Morigi M, Remuzzi G (2008) Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J Am Soc Nephrol 19:1158-1167
25. Boor P, Konieczny A, Villa L, Schult AL, Bucher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T (2007) Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol 18:1508-1515 (Pubitemid 46717517)
26. Long DA, Norman JT, Fine LG (2012) Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol 8:244-250
27. Maeshima Y, Makino H (2010) Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair 3:13
28. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK (2004) Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24:1246-1252 (Pubitemid 38880016)
29. Chade AR (2011) Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis. Am J Physiol Regul Integr Comp Physiol 300:R783-R790
30. Chen J, Hamm LL, Kleinpeter MA, Husserl F, Khan IE, Chen CS, Liu Y, Mills KT, He C, Rifai N, Simon EE, He J (2012) Elevated plasma levels of endostatin are associated with chronic kidney disease. Am J Nephrol 35:335-340
31. Cina DP, Xu H, Liu L, Farkas L, Farkas D, Kolb M, Margetts PJ (2011) Renal tubular angiogenic dysregulation in anti-Thy1.1 glomerulonephritis. Am J Physiol Renal Physiol 300:F488-F498
32. Tanaka T, Nangaku M (2009) Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD. J Pharmacol Sci 109:24-31
33. Kvam FI, Ofstad J, Iversen BM (2000) Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats. Kidney Blood Press Res 23:376-384
34. Baylis C (2012) Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens 21:1-6
35. Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S (2007) Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J Am Soc Nephrol 18:1525-1533 (Pubitemid 46717519)
36. Lewy PR, Quintanilla A, Levin NW, Kessler RH (1973) Renal energy metabolism and sodium reabsorption. Annu Rev Med 24:365-384
37. Kurnik BR, Weisberg LS, Kurnik PB (1992) Renal and systemic oxygen consumption in patients with normal and abnormal renal function. J Am Soc Nephrol 2:1617-1626
38. Kraut JA, Madias NE (2011) Consequences and therapy of the metabolic acidosis of chronic kidney disease. Pediatr Nephrol 26:19-28
39. Kraut JA (2011) Effect of metabolic acidosis on progression of chronic kidney disease. Am J Physiol Renal Physiol 300:F828-F829
40. Phisitkul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab MH, Wesson DE (2010) Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int 77:617-623
41. Susantitaphong P, Sewaralthahab K, Balk EM, Jaber BL, Madias NE (2012) Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Am J Nephrol 35:540-547
42. Wesson DE, Simoni J, Broglio K, Sheather S (2011) Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J Physiol Renal Physiol 300:F830-F837
43. Nath KA, Hostetter MK, Hostetter TH (1985) Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 76:667-675 (Pubitemid 15023121)
44. Souma T, Abe M, Moriguchi T, Takai J, Yanagisawa-Miyazawa N, Shibata E, Akiyama Y, Toyohara T, Suzuki T, Tanemoto M, Abe T, Sato H, Yamamoto M, Ito S (2011) Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells. J Am Soc Nephrol 22:635-648
45. Goraya N, Wesson DE (2012) Acid-base status and progression of chronic kidney disease. Curr Opin Nephrol Hypertens 21:552-556
46. Wolf G (2005) Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis. Antioxid Redox Signal 7:1337-1345 (Pubitemid 41232531)
47. Miki H, Funato Y (2012) Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species. J Biochem 151:255-261
48. Ray PD, Huang BW, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24:981-990
49. Okamura DM, Himmelfarb J (2009) Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease. Pediatr Nephrol 24:2309-2319
50. Fassett RG, Gobe GC, Peake JM, Coombes JS (2010) Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis 56:728-742
51. Guzy RD, Schumacker PT (2006) Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91:807-819 (Pubitemid 44266577)
52. Rubartelli A, Sitia R (2009) Stress as an intercellular signal: the emergence of stress-associated molecular patterns (SAMP). Antioxid Redox Signal 11:2621-2629
53. Rigoulet M, Yoboue ED, Devin A (2011) Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. Antioxid Redox Signal 14:459-468
54. Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, Abboud HE, Barnes JL (2010) NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21:93-102
55. Ramkumar N, Kohan DE (2013) Proximal tubule angiotensinogen modulation of arterial pressure. Curr Opin Nephrol Hypertens 22:32-36
56. Brezniceanu ML, Lau CJ, Godin N, Chenier I, Duclos A, Ethier J, Filep JG, Ingelfinger JR, Zhang SL, Chan JS (2010) Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J Am Soc Nephrol 21:943-954
57. Godin N, Liu F, Lau GJ, Brezniceanu ML, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS (2010) Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int 77:1086-1097
58. Kim J, Seok YM, Jung KJ, Park KM (2009) Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am J Physiol Renal Physiol 297:F461-F470
59. Carracedo J, Merino A, Briceno C, Soriano S, Buendia P, Calleros L, Rodriguez M, Martin-Malo A, Aljama P, Ramirez R (2011) Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J 25:1314-1322
60. Arellano-Mendoza MG, Vargas-Robles H, Del Valle-Mondragon L, Rios A, Escalante B (2011) Prevention of renal injury and endothelial dysfunction by chronic L-arginine and antioxidant treatment. Ren Fail 33:47-53
61. An WS, Kim HJ, Cho KH, Vaziri ND (2009) Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol 297:F895-F903
62. Semenza GL (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474-1480 (Pubitemid 30217451)
63. Simon MC, Keith B (2008) The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 9:285-296 (Pubitemid 351430845)
64. Higgins DF, Kimura K, Iwano M, Haase VH (2008) Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 7:1128-1132 (Pubitemid 351749261)
65. Neusser MA, Lindenmeyer MT, Moll AG, Segerer S, Edenhofer I, Sen K, Stiehl DP, Kretzler M, Grone HJ, Schlondorff D, Cohen CD (2010) Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol 176:594-607
66. Sun S, Ning X, Zhang Y, Lu Y, Nie Y, Han S, Liu L, Du R, Xia L, He L, Fan D (2009) Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 75:1278-1287
67. Basu RK, Hubchak S, Hayashida T, Runyan CE, Schumacker PT, Schnaper HW (2011) Interdependence of HIF-1alpha and TGF-beta/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am J Physiol Renal Physiol 300:F898-F905